Skip to main content
Terug
Watch Compare

Electromedical Technologies, Inc

Datakwaliteit: 100%
EMED
OTC Manufacturing Measuring & Analyzing Instruments
€ 0,00
€ 0,00 (0,00%)
Marktkapitalisatie: 667.858,0
Prijs
€ 0,00
Marktkapitalisatie
667.858,0
Dagbereik
€ 0,00 — € 0,00
52-Weeksbereik
€ 0,00 — € 0,00
Volume
10
Openen € 0,00
50D / 200D Gem.
€ 0,00
0,00% above
50D / 200D Gem.
€ 0,00
0,00% above

Quick Summary

Belangrijkste Punten

Negative free cash flow of -131.211,0
Capital efficient — spends only 0,00% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)17,30%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-190,83%
Op. Margin-114,92%

Veiligheid

Debt / Equity
N/A
Current Ratio0,07
Interest Coverage-4,38

Waardering

PE (TTM)
-0,40
Boven sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,4 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -190,8 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17,30% Revenue Growth (3Y) 35,19%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 879.484,0 Net Income (TTM) -1,68 M
ROE N/A ROA -272,07%
Gross Margin 78,71% Operating Margin -114,92%
Net Margin -190,83% Free Cash Flow (TTM) -131.211,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,07
Interest Coverage -4,38 Asset Turnover 1,43
Working Capital -4,05 M Tangible Book Value -4,00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,40 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,76
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19,65%
Market Cap 667.858,0 Enterprise Value 633.049,0
Per Share
EPS (Diluted TTM) 0,01 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion 7,82%
SBC-Adj. FCF -141.711 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2020 FY2021
Revenue 1,35 M 1,15 M 737.958,0 907.362,0
Net Income -2,64 M -3,47 M -3,87 M -8,48 M
EPS (Diluted) 0,00 -0,03 — -0,24
Gross Profit 1,05 M 888.641,0 543.574,0 708.128,0
Operating Income -2,06 M -1,60 M -3,17 M -3,80 M
EBITDA — — — —
R&D Expenses 231.434,0 92.299,0 31.600,0 215.320,0
SG&A Expenses 3,11 M 2,49 M 3,71 M 4,51 M
D&A 4.557,0 21.875,0 21.875,0 21.875,0
Interest Expense 893.155,0 791.072,0 769.591,0 3,31 M
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2020 FY2021
Total Assets 748.383,0 1,35 M 1,42 M 1,40 M
Total Liabilities 3,62 M 3,57 M 2,74 M 2,12 M
Shareholders' Equity -2,87 M -2,22 M -1,32 M -722.503,0
Total Debt 150.000,0 671.525,0 732.266,0 702.780,0
Cash & Equivalents 87.704,0 368.425,0 264.913,0 383.170,0
Current Assets 449.185,0 647.802,0 647.179,0 674.767,0
Current Liabilities 3,36 M 2,92 M 2,02 M 1,44 M